Answers are grounded in this paper and cite their sources.
Abstract Background Osteoporosis is a process of bone tissue destruction jointly caused by chronic inflammation and oxidative stress. Indole-3-propionic acid (IPA), as a metabolic molecule of the gut microbiota, exerts anti-inflammatory and antioxidant properties. However, the role of IPA in ovariectomy-induced osteoporosis in rats remains unclear. Methods We utilized ELISA and qRT-PCR to measure cytokine levels in serum and the mRNA expression of bone metabolism-related genes, respectively. Meanwhile, bone microstructure was analyzed using CT scanning technology. Additionally, we conducted non-targeted metabolomics and 16S rDNA gene sequencing studies on mouse fecal samples, employing multivariate statistical analysis for data visualization. Results IPA administration significantly attenuated the elevation of inflammatory mediators (TNF-α, IL-1β, IL-6) in OVX rats, while enhancing anti-inflammatory IL-10 levels. It could alter biochemical markers (Ca, P, ALP, CTX-1 and PINP) and suppress the expression of critical osteoclast differentiation genes (NFATc1, CTSK, ACP5, OSCAR), preventing OVX-induced bone loss. Additionally, the bone microstructure improved. Metabolomic profiling revealed IPA's regulatory role in fatty acid and amino acid metabolic pathways. Phloretin may serve as biomarker for the bone-protective effects of IPA. Additionally, IPA restored the balance of the Bacteroidota/Firmicutes gut microbiota. Conclusion These findings underscore IPA's therapeutic potential, providing a scientific rationale for developing IPA-based interventions for osteoporosis management.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: